Results 1 to 10 of about 1,552 (110)
Are topical keratolytic agents needed in the treatment of scalp psoriasis? [PDF]
Dermatology Online Journal, 2014 Topical corticosteroids are the primary treatment for scalp psoriasis. Keratolytic agents are promoted as adjunctive treatments. However, complex treatment regimens may result in poor adherence and outcomes.To evaluate the evidence for the need for use of topical keratolytic agents as opposed to topical corticosteroid monotherapy in the treatment of ...
Jenna L O'Neill, Arash Taheri
exaly +5 more sources
The treatment of plantar warts with a keratolytic agent and occlusion
Journal of Dermatological Treatment, 1991 In an open, multicentre study, patients with one to ten plantar warts on each foot were randomized prior to treatment for up to 17 weeks to receive either a keratolytic agent alone (Promicid gel) or the same agent covered by an occlusive plaster (Promicid occlusive dressing). A total of 170 patients completed the study.
Niels K Veien, R Lindskov, D Stahl
exaly +2 more sources
Dermatological Effects of Different Keratolytic Agents on Acne Vulgaris
Journal of Clinical Trials, 2016 Acne vulgaris is a chronic inflammatory skin disease; it's one of the most common skin disorders and affects mainly adolescents and young adults. Keratolytic agents are widely used in treatment of acne from several years. In this study we aimed to evaluate and compare the cutaneous response of different keratolytic agents in management of acne vulgaris.
exaly +2 more sources
Metabolomics in Scalp Seborrheic Dermatitis Evidenced Key Changes in Inflammatory Markers Following a 10-Week Scalp Care Scheme with an Anti-dandruff Shampoo [PDF]
Dermatology and TherapyIntroduction Mild-to-moderate scalp seborrheic dermatitis (SD) is commonly managed by using anti-SD shampoos containing antifungal, anti-inflammatory, and keratolytic agents.
Camille Géniès +16 more
doaj +2 more sources
Psoriasis part 2 – topical treatment, phototherapy and skin care [PDF]
Farmacja Polska, 2023 Psoriasis is a chronic inflammatory disease that requires the selection of appropriate pharmacotherapy and skin care. Topical treatment should be added in pharmacotherapy of every patient with psoriasis.
Ewa Zwierzyńska +2 more
doaj +1 more source
Response of papillon–Lefevre syndrome to acitretin
Indian Journal of Paediatric Dermatology, 2021 Papillon–Lefevre (PLS) is a rare autosomal recessive disorder of keratinization characterized by symmetric, trans-gradient type palmoplantar keratoderma (PPK), rapidly progressive periodontopathy, and precocious loss of dentition.
Priyanka Arun Kowe +3 more
doaj +1 more source
Psoriasis in areas difficult to treat and biological therapy
Przegląd Dermatologiczny, 2021 Psoriasis often affects specific locations such as the nail apparatus, scalp, hands, feet, and genital areas. It usually coexists with severe plaque psoriasis. However in some cases only these areas may be affected, causing a significant deterioration of
Anna Lis-Święty, Aleksandra Frątczak
doaj +1 more source
Exuberant clinical picture of Buschke-Fischer-Brauer palmoplantar keratoderma in bedridden patient [PDF]
Anais Brasileiros de Dermatologia, 2014 Buschke-Fisher-Brauer keratoderma is a rare hereditary autosomal dominant disease of incomplete penetrance. Important differential diagnoses include other palmoplantar keratinization disorders, acquired or hereditary, which is done based on the ...
João Roberto Antonio +3 more
doaj +2 more sources
Nevoid Hyperkeratosis of the Nipple – A Case Report and Review of Literature
Clinical Dermatology Review, 2023 Nevoid hyperkeratosis of the nipple and areola (NHNA) is a rare, benign, idiopathic condition, which occurs predominantly in women of child-bearing age.
B M Shashi Kumar, Savitha A Somaiah
doaj +1 more source